Home/Pipeline/InVision-Plus® Pediatric/NICU Line

InVision-Plus® Pediatric/NICU Line

Vascular access safety for pediatric and neonatal patients

CommercialActive

Key Facts

Indication
Vascular access safety for pediatric and neonatal patients
Phase
Commercial
Status
Active
Company

About RyMed Technologies

RyMed Technologies, founded in 2003 and headquartered in Franklin, Tennessee, is a private medical device company commercializing its proprietary InVision-Plus® needle-free IV connectors. Its core technology, Neutral Advantage Technology, is built around a '10-Point Standard' that addresses key failure points in IV therapy, such as infection and occlusion, through a fail-safe engineering design. The company is revenue-generating with a commercial-stage product line, recently expanding into pediatric and NICU populations. RyMed operates in the competitive vascular access segment, positioning its products as a premium standard for safety and clinical efficacy.

View full company profile